On December 30, Xunfei Healthcare Technology Co., Ltd. (Stock abbreviation: "Xunfei Healthcare", stock code: 02506.HK) was officially listed on the Hong Kong Stock Exchange. This is the first medical model stock listed on the Hong Kong Stock Exchange, and it is also the only A-share company spin-off listed enterprise filed by the China Securities Regulatory Commission in 2024.
As a holding subsidiary of iFLYTEK Co., Ltd., Xunfei Healthcare Technology Co., Ltd. focuses on the development and application of medical artificial intelligence technology. Xunfei Healthcare has established a core technological framework centered around DNNs, DL and MKGs, as well as proprietary core technologies in areas such as speech recognition, image recognition and NLU in the healthcare domain. According to Frost and Sullivan's data, its 2023 revenue scale ranks first in China's medical artificial intelligence industry.
Clifford Chance served as American lawyer and Hong Kong lawyer for the issuer.
CM Law Firm acted as the issuer's China legal counsel.
Pillsbury Winthrop Shaw Pittman LLP advised on U.S. export control and sanctions laws.
DLA Piper provided Hong Kong law advice to the joint sponsors.
King & Wood Mallesons was the China lawyers of the joint sponsors.